Xinyi Zhang
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Ribonucleotide reductase regulatory subunit M2 as a macromolecular target bridging small cell lung cancer progression and SARS-CoV-2 infection.
Journal: International journal of biological macromolecules
Published: December 20, 2025
Exploratory multiomics analysis identifies WDR17 as a potential biomarker of tyrosine kinase inhibitor resistance in lung adenocarcinoma.
Journal: Discover oncology
Published: December 12, 2025
Inverse Association Between Triglyceride-Glucose Index and Ischemic Stroke in Hospitalized Patients with Chronic Obstructive Pulmonary Disease and Atrial Fibrillation: A Retrospective Analysis.
Journal: International journal of chronic obstructive pulmonary disease
Published: August 06, 2025
Primary tumor resection: a new hope or an old illusion for patients with metastatic non-small cell lung neuroendocrine tumors?
Journal: World journal of surgical oncology
Published: April 13, 2025
Tracheal, bronchus, and lung cancer among older adults: thirty-year global burden trends, precision medicine breakthroughs, and lingering barriers.
Journal: BMC cancer
Published: March 17, 2025
Advances in cuproptosis harnessing copper-based nanomaterials for cancer therapy.
Journal: Journal of materials chemistry. B
Published: February 04, 2025
Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization.
Journal: Diabetology & metabolic syndrome
Published: January 29, 2025
Early death incidence and prediction in stage IV large cell neuroendocrine carcinoma of the lung.
Journal: Medicine
Published: September 17, 2024
"On-On-Off" Recyclable Fluorescence Battery for Direct and Selective Detection of Glyphosate and Cu2.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: June 11, 2024
TLR2 Activation as a Marker of Severe COVID-19 and a Potential Therapeutic Target.
Journal: Current medicinal chemistry
Published: June 02, 2024
Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damage.
Journal: Acta biomaterialia
Published: May 24, 2024
Last Updated: 09/26/2026